UT MD Anderson study finds link between statins and improved survival in inflammatory breast cancer

Early results show benefit in most dangerous form of disease

2012-12-06

(Press-News.org) HOUSTON - Researchers from The University of Texas MD Anderson Cancer Center found statins, the commonly used drug to lower cholesterol, improved progression-free survival in patients with inflammatory breast cancer (IBC).

The retrospective study was presented today in a poster discussion at the 2012 CTRC-AACR San Antonio Breast Cancer Symposium and follows a previously reported Danish study indicating there is some evidence to suggest the anti-inflammatory properties of statins could reduce the risk of breast cancer recurrence. Still, the overall effects of statins have not been examined in relation to IBC.

IBC is a rare type of breast cancer that develops quickly when malignant cells block lymph vessels in the skin and soft tissue. It accounts for only 1-5 percent of all invasive breast cancers, according to the American Cancer Society.

"We decided to take a different approach with the smaller population of inflammatory breast cancer patients and see if it's truly an inflammatory disease, whether or not there's some substantial impact of statin use in this population," said Naoto T. Ueno, M.D., Ph.D., professor in MD Anderson's Department of Breast Medical Oncology and executive director of the Morgan Welch Inflammatory Breast Cancer Research Program and Clinic.

Ueno, the corresponding author, and his colleagues reviewed 724 patients diagnosed and treated for stage III inflammatory breast cancer at MD Anderson between 1995 and 2011. Patients with records indicating statin use at the time of diagnosis were compared to those who were not taking statins. In total, the stage III group contained 74 statin users and 650 non-users.

The primary end-point was progression-free survival (PFS), while secondary end-points measured overall survival (OS) and disease-specific survival (DSS).

Additionally, researchers compared the clinical outcomes of those in the statin group based on the type of statin, lipophilic (fat-soluble) or hydrophilic (water-soluble), an important distinction as differences in survival emerged throughout the trial. The authors note patients who used both drug categories, or patients missing information on their specific statin type, were excluded from the survival estimates.

Outcomes Show Improvement

Patients with no record of statin use had 1.76 years DFS, while patients who took lipophilic statins saw improved survival rates of 2.47 years. The greatest improvement in survival was noted in patients with past hydrophilic statin use at 4.88 years.

Increased survival rates also extended to the DSS end-point. Patients with no statin use measured a DSS of 4.52 years, while hydrophilic patients measured 5.10 years.

The authors note there is a trend in overall survival, however the OS end-point did not reach statistical significance.

"The previous Danish study looking at statins examined a much larger group of participants, around 10,000 and more. So we're talking about a much smaller set of inflammatory breast cancer patients and to see the significant improvement in survival gives us a new perspective on the use of statins," said Ueno.

While Ueno added the findings are encouraging, the study does have limitations. First, no data was available describing how long patients had been taking statins, or for what indication. Those who did use statins may represent a population with better access to health care, a more health-conscious lifestyle and a higher education level, according to the researchers.

"This is an existing drug that was not developed for cancer and while developing new agents is important, statins are currently in the market and may have a significant role in the treatment we provide," he said.

Additional Research Warranted

MD Anderson researchers are planning prospective randomized studies in IBC patients to better evaluate the potential survival benefits of statins. Further studies also hope to identify what subset of populations would be best suited for statin use. Ueno said there is an important convenience factor involved, as participants can take statins anywhere and require only occasional follow-up.

INFORMATION:

This research was supported by National Institute of Health grants, an MD Anderson Cancer Center Support Grant, the Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, and the State of Texas Rare and Aggressive Breast Cancer Research Program Grant.

In addition to Ueno, other authors on the all MD Anderson study include: Takae Brewer, M.D., Hiroko Masuda, M.D., Ph.D., Gabriel Hortobagyi, M.D., Kazuharu Kai, M.D., Ph.D., Takayuki Iwamoto, M.D., and of the Department of Breast Medical Oncology; James Reuben, Ph.D., Department of Hematopathology; Peiying Yang, Ph.D., Integrative Medicine Program; Chad Barnett, Pharm.D., Division of Pharmacy; Ping Liu, Department of Biostatistics; and Wendy Woodward, M.D., Ph.D., Department of Radiation Oncology.

[Attachments] See images for this press release:

ELSE PRESS RELEASES FROM THIS DATE:

Insect-eating bat outperforms nectar specialist as pollinator of cactus flowers

2012-12-06

SANTA CRUZ, CA--Of the two bat species known to visit the flowers of the cardon cactus in Baja California, one depends entirely on nectar and is highly specialized to feed from the flowers, which are adapted for pollination by bats. The other is an insect-eating bat best known for its ability to hear the footsteps of large insects and scorpions and capture them on the ground. In a surprising result, scientists at the University of California, Santa Cruz, have found that the insect-eating pallid bat is a more effective pollinator of the cactus flowers than the nectar-feeding ...

Tamoxifen trial should prompt breast cancer patients to reconsider treatment options

2012-12-06

MAYWOOD, Il. - A groundbreaking clinical trial involving the breast cancer drug tamoxifen should prompt certain breast cancer patients to reconsider their treatment options, according to Loyola University Medical Center breast cancer specialist Dr. Kathy Albain. The trial is called ATLAS (Adjuvant Tamoxifen Longer Against Shorter). It included women with estrogen receptor-positive breast cancer that had not spread to distant organs. Women who took tamoxifen for 10 years had a lower risk of recurrence and lower mortality rate than women who took the drug for 5 years, ...

Fit kids finish first in the classroom

2012-12-06

EAST LANSING, Mich. — Fit kids aren't only first picked for kickball. New research from Michigan State University shows middle school students in the best physical shape outscore their classmates on standardized tests and take home better report cards. Published in the Journal of Sports Medicine and Physical Fitness, it's the first study linking children's fitness to both improved scores on objective tests and better grades, which rely on subjective decisions by teachers. The study also is among the first to examine how academic performance relates to all aspects of ...

Eating fewer, larger meals may prove healthier for obese women

2012-12-06

COLUMBIA, Mo. – Media articles and nutritionists alike have perpetuated the idea that for healthy metabolisms individuals should consume small meals multiple times a day. However, new research conducted at the University of Missouri suggests all-day snacking might not be as beneficial as previously thought, especially for obese women. "Our data suggests that, for obese women, eating fewer, bigger meals may be more advantageous metabolically compared to eating smaller, more frequent meals throughout the day," said the study's lead author, Tim Heden, a doctoral student ...

Fire and ice: Wildfires darkening Greenland snowpack, increasing melting

2012-12-06

SAN FRANCISCO—Satellite observations have revealed the first direct evidence of smoke from Arctic wildfires drifting over the Greenland ice sheet, tarnishing the ice with soot and making it more likely to melt under the sun. At the American Geophysical Union meeting this week, an Ohio State University researcher presented images from NASA's Cloud-Aerosol Lidar and Infrared Pathfinder Satellite Observation (CALIPSO) satellite, which captured smoke from Arctic fires billowing out over Greenland during the summer of 2012. Jason Box, associate professor of geography at ...

Georgia State physicist, international researchers discover fastest light-driven process

2012-12-06

A discovery that promises transistors – the fundamental part of all modern electronics – controlled by laser pulses that will be 10,000 faster than today's fastest transistors has been made by a Georgia State University professor and international researchers. Professor of Physics Mark Stockman worked with Professor Vadym Apalkov of Georgia State and a group led by Ferenc Krausz at the prestigious Max Planck Institute for Quantum Optics and other well-known German institutions. There are three basic types of solids: metals, semiconductors, used in today's transistors, ...

X-ray laser helps slay parasite that causes sleeping sickness

2012-12-06

An international team of scientists, using the world's most powerful X-ray laser, has revealed the three dimensional structure of a key enzyme that enables the single-celled parasite that causes African trypanosomiasis (or sleeping sickness) in humans. With the elucidation of the 3D structure of the cathepsin B enzyme, it will be possible to design new drugs to inhibit the parasite (Trypanosoma brucei) that causes sleeping sickness, leaving the infected human unharmed. The research team, including several ASU scientists, is led by the German Electron Synchrotron (DESY) ...

Researchers identify proteins that indicate which kidney tumors are most likely to spread

2012-12-06

TORONTO, Dec. 5, 2012—Researchers at St. Michael's hospital have identified 29 proteins that are likely to be involved in the spread of kidney cancer. The discovery will help physicians recognize which tumours are going to behave more aggressively and provide those patients with more intensive treatment and closer followup. "Metastatic renal cell carcinoma is one of the most treatment-resistant malignancies and patients have dismal prognosis," said Dr. George M Yousef, a laboratory pathologist. "Identification of markers that can predict the potential of metastases will ...

Clinical trial tests rice bran to prevent cancer

2012-12-06

A recent University of Colorado Cancer Center review in the journal Advances in Nutrition shows that rice bran offers promising cancer prevention properties. Meanwhile, an ongoing clinical trial is testing the effectiveness of rice bran in preventing the recurrence of colon cancer. "While I have been trained as a molecular toxicologist, I am excited about the opportunities to deliver bioactive, cancer fighting compounds with food, and this has led to my focus now primarily on the multiple drug-like characteristics of rice bran," says Elizabeth P. Ryan, PhD, CU Cancer ...

Adolescents under pressure to speak 'properly'

2012-12-06

EAST LANSING, Mich. — As adolescents transition to adulthood, the pressure to meet adult expectations – such as speaking properly – may be greater than expected, according to a new study by a Michigan State University researcher. Suzanne Evans Wagner, assistant professor of linguistics, has proven for the first time that language changes with age in addition to community pressures. And, surprisingly, college and post-high school ambitions play a huge role. "It seems as if in high school, students who want to go to a good college are the ones who early on begin to dial ...

UT MD Anderson study finds link between statins and improved survival in inflammatory breast cancer

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: